An intensified manufacturing process developed to support a trial of an Ebola vaccine in Uganda could help accelerate the production of other jabs in future health emergencies, according to Italian ...

A clinical-grade recombinant virus-like particle (VLP) vaccine has been developed to prevent human parvovirus B19 (HPVB19) infection, which can have severe and potentially fatal complications in ...

NANTES, France--(BUSINESS WIRE)--Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, ...

The MVA platform is uniquely designed to incorporate multiple antigens into a single vaccine. This versatility allows GeoVax to develop vaccines targeting multiple aspects of a single pathogen or ...

Despite increased funding towards malaria research and vaccine development, the number of deaths from the parasitic disease returned over the past three years to the high numbers seen in 2012, with ...

Experts discuss South Africa’s current vaccine manufacturing capabilities and the steps needed to prepare for future pandemics. WHEN Covid-19 pandemic hit in 2020, South Africa was caught short as it ...

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide 27.01.2025 / 15:04 CET/CEST The issuer is solely responsible for the content of this announcement. Process Expected ...